BSE Live
Oct 13, 16:01Prev. Close
993.45
Open Price
990.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 13, 15:59Prev. Close
993.45
Open Price
990.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
995.50 (595)
Balance Sheet of Zydus Lifesciences (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 102.40 | 102.40 | 102.40 | 102.40 | 102.40 | |
Total Share Capital | 102.40 | 102.40 | 102.40 | 102.40 | 102.40 | |
Reserves and Surplus | 11,157.80 | 8,466.80 | 7,643.10 | 6,515.90 | 6,173.80 | |
Total Reserves and Surplus | 11,157.80 | 8,466.80 | 7,643.10 | 6,515.90 | 6,173.80 | |
Total Shareholders Funds | 11,260.20 | 8,569.20 | 7,745.50 | 6,618.30 | 6,276.20 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 1,511.00 | 2,024.90 | 1,351.10 | 1,239.40 | 430.00 | |
Deferred Tax Liabilities [Net] | 198.30 | 156.60 | 193.60 | 105.50 | 184.60 | |
Other Long Term Liabilities | 12.00 | 9.30 | 8.70 | 8.20 | 13.90 | |
Long Term Provisions | 120.70 | 105.20 | 74.10 | 62.10 | 96.50 | |
Total Non-Current Liabilities | 1,842.00 | 2,296.00 | 1,627.50 | 1,415.20 | 725.00 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 1,443.40 | 1,317.90 | 1,300.90 | 1,545.60 | 604.30 | |
Trade Payables | 862.70 | 701.00 | 992.10 | 996.10 | 899.90 | |
Other Current Liabilities | 1,096.20 | 746.70 | 469.40 | 444.90 | 388.50 | |
Short Term Provisions | 47.00 | 40.30 | 28.30 | 27.30 | 29.30 | |
Total Current Liabilities | 3,449.30 | 2,805.90 | 2,790.70 | 3,013.90 | 1,922.00 | |
Total Capital And Liabilities | 16,551.50 | 13,671.10 | 12,163.70 | 11,047.40 | 8,923.20 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 4,064.40 | 3,801.20 | 2,545.40 | 2,205.00 | 1,998.60 | |
Intangible Assets | 44.60 | 131.30 | 134.80 | 147.00 | 156.20 | |
Capital Work-In-Progress | 552.60 | 674.90 | 659.20 | 678.40 | 296.80 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 4,661.60 | 4,607.40 | 3,339.40 | 3,030.40 | 2,451.60 | |
Non-Current Investments | 6,404.10 | 4,190.50 | 3,618.10 | 3,923.70 | 2,216.60 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 296.30 | 201.30 | 1,301.30 | 1,427.10 | 921.90 | |
Other Non-Current Assets | 396.80 | 409.90 | 347.50 | 526.80 | 409.80 | |
Total Non-Current Assets | 11,758.80 | 9,409.10 | 8,606.30 | 8,908.00 | 5,999.90 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 4.70 | 0.00 | 0.00 | 100.90 | |
Inventories | 1,394.70 | 1,472.50 | 1,320.70 | 932.90 | 657.50 | |
Trade Receivables | 2,456.70 | 2,112.10 | 1,255.10 | 929.00 | 1,707.30 | |
Cash And Cash Equivalents | 385.30 | 112.10 | 183.80 | 16.80 | 163.70 | |
Short Term Loans And Advances | 18.50 | 4.30 | 17.80 | 37.10 | 19.00 | |
OtherCurrentAssets | 537.50 | 556.30 | 780.00 | 223.60 | 274.90 | |
Total Current Assets | 4,792.70 | 4,262.00 | 3,557.40 | 2,139.40 | 2,923.30 | |
Total Assets | 16,551.50 | 13,671.10 | 12,163.70 | 11,047.40 | 8,923.20 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 4,090.90 | 3,592.60 | 2,855.10 | 2,594.20 | 1,791.30 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 1,450.40 | 1,159.30 | 1,124.20 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | 5,275.20 | 4,840.40 | 4,268.30 | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 72.97 | 72.97 | 72.97 | 72.97 | 72.97 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 4,835.00 | 4,872.00 | 3,410.40 | 2,509.00 | 2,140.00 | |
Non-Current Investments Unquoted Book Value | 5,098.90 | 2,866.30 | 3,454.50 | 3,805.90 | 2,112.60 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | 100.10 | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | 0.80 |
07.10.2025
19.09.2025
16.09.2025
10.09.2025
Zydus Life Standalone June 2025 Net Sales at Rs 2,588.30 crore, down 37.78% Y-o-Y
10.09.2025
Zydus Life Standalone June 2025 Net Sales at Rs 2,588.30 crore, down 37.78% Y-o-Y
24.06.2025
Zydus Life Consolidated March 2025 Net Sales at Rs 6,527.90 crore, up 17.96% Y-o-Y
21.05.2025
Zydus Life Standalone March 2025 Net Sales at Rs 5,819.60 crore, up 74.64% Y-o-Y
05.02.2025
Zydus Life Standalone December 2024 Net Sales at Rs 2,515.90 crore, up 6.1% Y-o-Y
12.07.2023
Zydus Lifescience Q1 PAT seen up 58.6% YoY to Rs 839.1 cr: Nirmal Bang
08.07.2022
Zydus Lifesciences Q1 PAT may dip 10.6% YoY to Rs 505.2 cr: Prabhudas Lilladher
13.01.2022
Cadila Healthcare Q3 PAT seen up 3.2% YoY to Rs 544 cr: Prabhudas Lilladher
06.10.2021
Cadila Healthcare Q2 PAT seen up 19% YoY to Rs 563.3 cr: Prabhudas Lilladher